Your session is about to expire
← Back to Search
Maternal Enteroviral Infection and Diabetes Impact on Congenital Heart Defects (CHARMED Trial)
CHARMED Trial Summary
This trial is looking at the role of maternal viral infections in Congenital Heart Disease (CHD). They will be looking at samples from two existing biorepositories and also doing a prospective study.
CHARMED Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CHARMED Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Healthy Non Pregnant Women (HNPW)
- Group 2: Diabetic Non Pregnant Women (DNPW)
- Group 3: Healthy Pregnant Women (HPW)
- Group 4: Diabetic Pregnant Women (DPW)
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the eligibility for this research limited to certain individuals?
"Patients hoping to enroll in this trial will need to have gestational diabetes and be between the ages of 18-45. The study is currently looking for 1500 participants."
To what extent is the current clinical trial administering treatments to participants?
"Affirmative. Clinicaltrials.gov's records show that the trial, which was first advertised on February 1st 2021, is actively enrolling participants at this time. There are 1500 available spots in total split between two different sites."
Is there still room for volunteers to join this research endeavor?
"Absolutely, the clinicaltrial.gov website confirms that this experiment is actively enrolling individuals. Initially posted on February 1st 2021 and recently updated August 2nd 2022, it seeks to enrol 1500 patients across two facilities."
Does this trial permit those aged 35 and over to participate?
"This trial is open to adults aged 18-45. There are other clinical trials available for younger applicants (599) and those over 65 years old (2190)."
Share this study with friends
Copy Link
Messenger